• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2015 NIHR Horizon Scanning Centre (NIHR HSC) Atezolizumab for locally advanced or metastatic non-small cell lung cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Bavituximab for advanced non-small cell lung cancer – second line in combination with docetaxel
2015 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with erlotinib (Tarceva) for EGFR positive, advanced or metastatic non-small cell lung cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for metastatic BRAF V600E positive non-small cell lung cancer
2015 NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab monotherapy for relapsed and refractory multiple myeloma
2015 NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma
2015 NIHR Horizon Scanning Centre (NIHR HSC) Gemtuzumab ozogamicin (Mylotarg) with conventional chemotherapy for acute myeloid leukaemia – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) MABp1 (Xilonix) for metastatic colorectal cancer –third line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab (Gazyvaro) for indolent non-Hodgkin lymphoma – first line, in combination with chemotherapy
2015 NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep (Reolysin) with or without chemotherapy for metastatic malignant melanoma – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep (Reolysin) in combination with chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for PD-L1 strong-positive metastatic non-small cell lung cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Glycerol phenylbutyrate (Ravicti) for urea cycle disorders (hyperammonaemia)
2015 NIHR Horizon Scanning Centre (NIHR HSC) GSK2696273 for severe combined immunodeficiency due to adenosine deaminase deficiency
2015 NIHR Horizon Scanning Centre (NIHR HSC) Lopixibat for progressive familial intrahepatic cholestasis in paediatric patients
2015 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for Crohn's disease, in patients intolerant or with an unsatisfactory response to immunosuppressive drugs and/or TNF-inhibitors
2015 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for primary and relapse-free secondary progressive multiple sclerosis – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for rheumatoid arthritis – second and subsequent line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Sirukumab for rheumatoid arthritis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Tadalafil (Cialis) for Duchenne muscular dystrophy
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ataluren (Translarna) for CFTR class I nonsense mutation mediated cystic fibrosis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Benralizumab for uncontrolled asthma – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Abiraterone (Zytiga) for hormone-naïve metastatic prostate cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with lomustine for glioblastoma – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Dacomitinib for locally advanced or metastatic EGFR positive non-small cell lung cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Fulvestrant (Faslodex) for advanced or metastatic, hormone-receptor positive breast cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib (Zydelig) with bendamustine and rituximab for chronic lymphocytic leukaemia – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for diffuse large B cell lymphoma –second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for recurrent glioblastoma – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab treated patients – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab naïve patients – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for recurrent or metastatic squamous cell carcinoma of the head and neck – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Olaratumab with doxorubicin for advanced soft tissue sarcoma
2015 NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for advanced or metastatic urothelial cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib (Stivarga) for hepatocellular carcinoma – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ribociclib for advanced hormone receptor positive, HER2 negative breast cancer – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Talazoparib for locally advanced and/or metastatic breast cancer with germline BRCA 1/2 positive mutation
2015 NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax for chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
2015 NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) for relapsed or refractory acute lymphoblastic leukaemia – third line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) in combination with chemotherapy for elderly patients with newly diagnosed CD20 positive diffuse large B-cell lymphoma – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Eprodisate disodium (Kiacta) for AA amyloidosis
2015 NIHR Horizon Scanning Centre (NIHR HSC) STG 320 for allergic rhinitis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
2015 NIHR Horizon Scanning Centre (NIHR HSC) Pridopidine (Huntexil) for Huntington's disease
2015 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept solution (Eylea) for visual impairment due to choroidal neovascularisation secondary to pathological myopia
2015 NIHR Horizon Scanning Centre (NIHR HSC) rhNGF for neurotrophic keratitis – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Abatacept for psoriatic arthritis – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Bimagrumab for sporadic inclusion body myositis – first line
2015 NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L (Prochymal) for steroid refractory acute graft versus host disease – second line
2015 NIHR Horizon Scanning Centre (NIHR HSC) XEN Gel Stent for glaucoma treatment
2015 NIHR Horizon Scanning Centre (NIHR HSC) Permaseal for soft tissue access and closure during procedures
2015 NIHR Horizon Scanning Centre (NIHR HSC) ENROUTE transcarotid neuroprotection and stent systems
2015 NIHR Horizon Scanning Centre (NIHR HSC) AventaMed device for tympanostomy tube placement
2015 NIHR Horizon Scanning Centre (NIHR HSC) Ostom-I Alert Sensor for use with ostomy bags
2015 NIHR Horizon Scanning Centre (NIHR HSC) Hand-held Fourier transform infrared (FTIR) spectroscopy to diagnose and monitor COPD
2015 NIHR Horizon Scanning Centre (NIHR HSC) Arsenal ResQFoam™ for non-compressible abdominal haemorrhage
2015 NIHR Horizon Scanning Centre (NIHR HSC) XStat® Hemostatic Device for non-compressible junctional haemorrhage
2015 NIHR Horizon Scanning Centre (NIHR HSC) Nitric Oxide generating gel dressing for diabetic foot ulcers
2015 NIHR Horizon Scanning Centre (NIHR HSC) Freedom Spinal Cord Stimulator System for chronic back and leg pain
2015 NIHR Horizon Scanning Centre (NIHR HSC) Inreda artificial pancreas device for Type 1 diabetes
2015 NIHR Horizon Scanning Centre (NIHR HSC) Rapid Rhythm ECG for atrial fibrillation
2015 NIHR Horizon Scanning Centre (NIHR HSC) Noctura 400 Sleep Mask for diabetic retinopathy
2015 NIHR Horizon Scanning Centre (NIHR HSC) OnPulse™ nerve stimulation technology for urinary and faecal incontinence
2015 NIHR Horizon Scanning Centre (NIHR HSC) Fall-Safe Assist device for the prevention and detection of falls
2015 NIHR Horizon Scanning Centre (NIHR HSC) Reza Band® for laryngopharyngeal reflux
2015 NIHR Horizon Scanning Centre (NIHR HSC) Sonata™ System for the removal of uterine fibroids
2015 NIHR Horizon Scanning Centre (NIHR HSC) Lithoplasty® balloon catheter for peripheral arterial disease
2015 NIHR Horizon Scanning Centre (NIHR HSC) Serenity System® to treat tinnitus
2015 NIHR Horizon Scanning Centre (NIHR HSC) MolecuLight i:X for visualisation of bacteria in chronic wounds
2015 NIHR Horizon Scanning Centre (NIHR HSC) BuddyWOTCH™ to monitor COPD
2015 NIHR Horizon Scanning Centre (NIHR HSC) ivWatch Model 400 patient monitor for continuous monitoring of IV sites
2015 NIHR Horizon Scanning Centre (NIHR HSC) WavSTAT4 Optical Biopsy System® for colorectal cancer diagnosis
2015 NIHR Horizon Scanning Centre (NIHR HSC) Cerepress™ and Vittamed 205™ for non-invasive intracranial pressure measurement
2015 NIHR Horizon Scanning Centre (NIHR HSC) Seralite® for multiple myeloma and other B cell dyscrasias
2015 NIHR Horizon Scanning Centre (NIHR HSC) The Nottingham Prognostic Index Plus test for breast cancer management
2015 NIHR Horizon Scanning Centre (NIHR HSC) IRIDICA system for detection and identification of microbial pathogens in critically-ill patients
2015 NIHR Horizon Scanning Centre (NIHR HSC) OncoBEAM RAS CRC for metastatic colorectal cancer
2015 NIHR Horizon Scanning Centre (NIHR HSC) myPath Melanoma for the diagnosis of malignant melanoma
2015 NIHR Horizon Scanning Centre (NIHR HSC) P1vital® eHealth Emotional Test Battery (eH-ETB) for early detection of treatment effect in depression
2015 NIHR Horizon Scanning Centre (NIHR HSC) ROCA® for the diagnosis of ovarian cancer
2015 NIHR Horizon Scanning Centre (NIHR HSC) Texture analysis of Radiological images (TexRAD) for lung cancer assessment
2015 NIHR Horizon Scanning Centre (NIHR HSC) Multistatic Array processing for Radiowave Image Acquisition (MARIA) for detection of breast tumours
2015 NIHR Horizon Scanning Centre (NIHR HSC) RhythmView™ system for cardiac arrhythmias
2015 NIHR Horizon Scanning Centre (NIHR HSC) OncAlert® and SensoDX OraTech™ for the diagnosis of oral cancer
2015 NIHR Horizon Scanning Centre (NIHR HSC) ClearSight™ MRI for breast cancer lumpectomy
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab (Avastin®) in combination with chemotherapy as second-line therapy for HER2-negative, locally recurrent or metastatic breast cancer that has progressed after first-line treatment with bevacizumab plus chemotherapy
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses]
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Nivolumab BMS®) for the second-line therapy of metastatic squamous non-small cell lung cancer
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ramucirumab in combination with paclitaxel as second-line treatment for adult patients with advanced gastric or gastro-oesophageal junction carcinoma
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carfilzomib (Kyprolis®) for patients with relapsed multiple myeloma who have received one to three prior lines of therapy
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review]
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment]
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment]
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) for the treatment of advanced melanoma
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Robot-assisted surgery: a systematic review of effectiveness and safety for elected indications and accumulating costs]
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [The effects of tangible and intangible incentives on health behaviour]
2015 New Zealand National Health Committee (NHC) Epidermal growth factor receptor gene mutation analysis testing assessment
2015 New Zealand National Health Committee (NHC) Percutaneous Left Atrial Appendage Occlusion (LAAO) for the prevention of stroke in non-valvular atrial fibrillation (AF) in the New Zealand health system